2 completed, 2 unknown, 1 recruiting. 4 Phase 2.
| Phase | Trials | Status |
|---|---|---|
| Phase 2 | 4 | Completed 2, Recruiting 1, Unknown 1 |
Follow Pheochromocytoma, Metastatic: new trials by email Literature Review of Pheochromocytoma, Metastatic trials Research Report on Pheochromocytoma, Metastatic
Tick up to 5 trials to compare them side by side (eligibility, arms, endpoints, adverse events) in a Literature Matrix.
| Trial | Phase | Status | Sponsor | Enrollment | Start | Updated |
|---|---|---|---|---|---|---|
| An Experimental Study of Belzutifan Impact on Catecholamine Metabolism Belzutifan - Pheochromocytoma and Paraganglioma (PPGL), Pheochromocytoma Malignant | Phase 2 | Recruiting | Cambridge University Hospitals NHS Foundation Trust | 12 | 2026-04-27 | 2026-07-02 |
| The Efficacy and Safety of Penpulimab in the Treatment of Metastatic PPGL Patients Who Fail to Other Systemic Treatment Penpulimab - Pheochromocytoma, Metastatic, Pheochromocytoma Malignant | Phase 2 | Unknown | Peking Union Medical College Hospital | 5 | 2023-04-01 | 2023-06-02 |
| Prediction and Evaluation of Anlotinib Treatment Response Using Contrast Enhanced Ultrasound PPGL Patients Contrast-enhanced ultrasound(CEUS) - Pheochromocytoma, Metastatic, Ultrasonography | Unknown | Peking Union Medical College Hospital | 20 | 2023-03-01 | 2023-08-29 | |
| The Efficacy and Safety of Anlotinib in Patients With Metastatic Pheochromocytoma or Paraganglioma anlotinib hydrochloride - Malignant Adrenal Gland Pheochromocytoma, Malignant Paraganglioma | Phase 2 | Completed | Peking Union Medical College Hospital | 27 | 2021-04-30 | 2024-06-12 |
| The Efficacy and Safety of Temozolomide in Patients With MPPGL Temozolomide capsule - Pheochromocytoma, Metastatic, Paraganglioma, Malignant | Phase 2 | Completed | Peking Union Medical College Hospital | 62 | 2019-10-01 | 2023-05-15 |
Neoplasm Metastasis (5) · Pheochromocytoma (5) · Paraganglioma, Extra-Adrenal (4) · Paraganglioma (3)
Neoplasms (5) · Neoplasms by Histologic Type (5) · Neoplasms, Germ Cell and Embryonal (5) · Neoplasms, Nerve Tissue (5) · Neoplastic Processes (5) · Neuroectodermal Tumors (5) · Neuroendocrine Tumors (5) · Pathologic Processes (5) · Pathological Conditions, Signs and Symptoms (5) · Paraganglioma (2)
Temozolomide (1) · anlotinib (1) · belzutifan (1) · penpulimab (1)
Peking Union Medical College Hospital (4) · Cambridge University Hospitals NHS Foundation Trust (1)
China (4) · United Kingdom (1)
Anli Tong (4) · Ruth T Casey, MD PhD (1)